Clinical trial
Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
NCT01790685 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- December 31, 2014
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.